当前位置: X-MOL 学术Curr. Opin. Pharmacol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Drug monitoring in systemic lupus erythematosus
Current Opinion in Pharmacology ( IF 4.0 ) Pub Date : 2022-04-28 , DOI: 10.1016/j.coph.2022.102225
Michelle Petri 1
Affiliation  

Therapeutic drug monitoring (TDM) is not yet accepted by systemic lupus erythematosus (SLE) treatment guidelines. Studies in SLE, however, have proven benefit in three areas: identification of non-adherence or poor adherence; targets for clinical benefit; and ranges of toxicity. This review covers the data on three medications commonly used for SLE, drawing on studies from both the SLE and non-SLE literature.



中文翻译:

系统性红斑狼疮的药物监测

治疗药物监测 (TDM) 尚未被系统性红斑狼疮 (SLE) 治疗指南所接受。然而,系统性红斑狼疮的研究已证明在三个方面有益: 识别不依从或依从性差;临床获益目标;和毒性范围。本综述涵盖了 SLE 常用的三种药物的数据,借鉴了 SLE 和非 SLE 文献中的研究。

更新日期:2022-04-28
down
wechat
bug